entity

Probiotics

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about Probiotics: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

7Connections
0Hypotheses
1Analyses
7Outgoing
0Incoming
0Experiments
1Debates

No AI portrait yet

Wiki Pages (2)

Knowledge base pages for this entity

Section 159: Microbiome Sequencing and Personalized Probiotics in CBS/PSP

therapeutic · 2513 words

Probiotics in Mild Alzheimer's Disease (NCT06181513)

clinical · 970 words

Outgoing (7)

TargetRelationTypeStr
Short-Chain Fatty Acidsassociated_withcompound0.80
Short-Chain Fatty Acidsupregulatescompound0.75
Alzheimer's Diseasetreatsdisease0.70
gut-liver-brain axisregulatespathway0.70
depressiontherapeutic_targetdisease0.70

Incoming (0)

SourceRelationTypeStr
No incoming edges

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (1)

Scientific analyses that reference this entity

How does engineered C. butyricum cross the blood-brain barrier to directly bind

neurodegeneration | 2026-04-15 | 2 hypotheses Top: 0.703

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (1)

Multi-agent debates referencing this entity

The abstract claims C. butyricum-GLP-1 crosses the BBB and binds to GLP-1 recept

closed · Rounds: 4 · Score: 0.95 · 2026-04-15